Carboxyatractyloside poisoning in humans

dc.contributor.authorTurgut, M
dc.contributor.authorAlhan, CC
dc.contributor.authorGürgöze, M
dc.contributor.authorKurt, A
dc.contributor.authorDogan, Y
dc.contributor.authorTekatli, M
dc.contributor.authorAygün, D
dc.date.accessioned2026-08-12T16:34:34Z
dc.date.issued2005
dc.departmentFırat Üniversitesi
dc.description.abstractObjective: Cocklebur (Xanthium strumarium) is an herbaceous annual plant with worldwide distribution. The seeds contain the glycoside carboxyatracryloside, which is highly toxic to animals. We describe nine cases of carboxyatractyloside poisoning in humans which, to our knowledge, has not previously been reported. The clinical, laboratory and histopathological findings and our therapeutic approach are also discussed. Subjects and methods: The patients presented with acute onset abdominal pain, nausea and vomiting, drowsiness, palpitations, sweating and dyspnoea. Three of them developed convulsions followed by loss of consciousness and death. Results: Laboratory findings showed raised liver enzymes, indicating severe hepatocellular damage. BUN and creatinine levels were raised, especially in the fatal cases who also displayed findings of consumption coagulopathy. CPK-MB values indicative of myocardial injury were also raised, especially in the fatal cases. Three of the patients died within 48 hours of ingesting carboxyatractyloside. Post-mortem histopathology of the liver confirmed centrilobular hepatic necrosis and renal proximal tubular necrosis, secondary changes owing to increased permeability and microvascular haemorrrage in the cerebrum and cerebellum, and leucocytic infiltrates in the muscles and various organs including pancreas, lungs and myocardium. Conclusions: Carboxyatractyloside poisoning causes multiple organ dysfunction and can be fatal. Coagulation abnormalities, hyponatraemia, marked hypoglycaemia, icterus and hepatic and renal failure are signs of a poor prognosis. No antidote is available and supportive therapy is the mainstay of treatment.
dc.identifier.doi10.1179/146532805X45728
dc.identifier.endpage134
dc.identifier.issn0272-4936
dc.identifier.issue2
dc.identifier.orcid0000-0002-9138-2117
dc.identifier.orcid0000-0002-4430-444X
dc.identifier.orcid0000-0001-9738-9611
dc.identifier.pmid15949201
dc.identifier.scopus2-s2.0-23644434955
dc.identifier.scopusqualityN/A
dc.identifier.startpage125
dc.identifier.urihttps://doi.org/10.1179/146532805X45728
dc.identifier.urihttps://hdl.handle.net/11508/44519
dc.identifier.volume25
dc.identifier.wosWOS:000231540400008
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherManey Publishing
dc.relation.ispartofAnnals of Tropical Paediatrics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectPentobarbital-Anesthetized Dogs
dc.subjectXanthium-Strumarium
dc.subjectAtractylis-Gummifera
dc.subjectActive Principle
dc.subjectCocklebur
dc.subjectRats
dc.subjectInhibitors
dc.titleCarboxyatractyloside poisoning in humans
dc.typeArticle

Dosyalar